Stockscreener 앱 받기
3.64
1.11%
0.04
시간 외 거래:
3.62
-0.02
-0.55%
전일 마감가:
$3.60
열려 있는:
$3.64
하루 거래량:
72,449
Relative Volume:
1.04
시가총액:
$2.46M
수익:
$4.79M
순이익/손실:
$-13.42M
주가수익비율:
-0.9055
EPS:
-4.02
순현금흐름:
$-10.30M
1주 성능:
-15.15%
1개월 성능:
-56.46%
6개월 성능:
-75.15%
1년 성능:
-89.89%
1일 변동 폭
$3.3358
$3.72
1주일 범위
$3.3358
$4.5558
52주 변동 폭
$3.3358
$39.13
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
명칭
Qualigen Therapeutics Inc
전화
(760) 918-9165
주소
2042 CORTE DEL NOGAL, CALIFORNIA
QLGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| QLGN | 3.64 | 2.46M | 4.79M | -13.42M | -10.30M | -4.02 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Qualigen Therapeutics Inc 주식(QLGN)의 최신 뉴스
Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World
Qualigen Therapeutics Inc (QLGN) Quarterly 10-Q Report - Quartzy
Qualigen Therapeutics appoints new board member - Investing.com
QLGN Stock Touches 52-Week Low at $3.71 Amid Market Challenges - Investing.com Canada
Qualigen Therapeutics announces 1-for-50 reverse stock split - Investing.com India
Qualigen Therapeutics announces 1-for-50 reverse stock split By Investing.com - Investing.com UK
Qualigen Therapeutics (STU:7R90) Enterprise Value : €4.58 Mil (As of Nov. 07, 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Operating Cash Flow per Sh - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Shares Outstanding (EOP) : 0.19 Mil (As of Jun. 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Long-Term Debt & Capital L - GuruFocus.com
Qualigen Therapeutics (STU:7R90) EV-to-Revenue : (As of Nov. 07, 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Cash Flow from Financing : €1.51 Mil (TTM As of Jun. 2024) - GuruFocus.com
Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Qualigen Therapeutics, Inc. Announces Appointment of Amy Broidrick as Executive Vice President and Chief Strategy Officer - Marketscreener.com
QLGN stock touches 52-week high at $5.05 amid market fluctuations - Investing.com
Qualigen Therapeutics Stock to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN) - Defense World
Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewswire
Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split - TipRanks
Would I Buy Qualigen Therapeutics Inc (NASDAQ: QLGN) Stock At Any Time In The Future? - Stocks Register
Qualigen Therapeutics announces results of annual stockholder meeting By Investing.com - Investing.com Australia
Qualigen Therapeutics announces results of annual stockholder meeting - Investing.com India
Qualigen Therapeutics (STU:7R9) Enterprise Value : €4.47 Mil (As of Oct. 26, 2024) - GuruFocus.com
Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - openPR
QLGN stock touches 52-week low at $0.11 amid market challenges - Investing.com India
Qualigen Therapeutics faces Nasdaq delisting notice By Investing.com - Investing.com Canada
Qualigen Therapeutics faces Nasdaq delisting notice - Investing.com India
Qualigen Therapeutics (NASDAQ:QLGN) Shares Up 4.4% – Here’s Why - Defense World
Qualigen Therapeutics appoints new director and audit chair By Investing.com - Investing.com South Africa
Qualigen Therapeutics appoints new director and audit chair - Investing.com India
Qualigen Therapeutics sees major executive reshuffle By Investing.com - Investing.com Canada
Qualigen Therapeutics, Inc. Announces management changes. - The Manila Times
Qualigen Therapeutics appoints new leadership amid strategic shift By Investing.com - Investing.com South Africa
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Sees Large Decline in Short Interest - Defense World
Qualigen Therapeutics sees major executive reshuffle - Investing.com
Qualigen Therapeutics appoints new leadership amid strategic shift - Investing.com
Qualigen Therapeutics Announces Executive Shakeup and Board Revamp - TipRanks
Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex
Qualigen Therapeutics granted Nasdaq listing extension - Investing.com
Qualigen Therapeutics granted Nasdaq listing extension By Investing.com - Investing.com Australia
Qualigen Therapeutics receives extension from Nasdaq hearings panel - TipRanks
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewswire
Garner Asset Management Corp Purchases 1,151 Shares of QUALCOMM Incorporated (NASDAQ:QCOM) - Defense World
Quorn faces £63.4m loss as UK and US meat-free market sales decline - Express
QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuity - Zacks Investment Research
Choreo LLC Makes New $264,000 Investment in Qualys, Inc. (NASDAQ:QLYS) - Defense World
Quorn: Meat-free food brand loses more than £60m as supermarket sales slashed - City A.M.
Qualigen Therapeutics Inc (QLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):